On April 24, 2026, Z Squared Inc. merged with Coeptis Therapeutics Holdings, Inc., becoming a wholly owned subsidiary and changing its name to Z Squared OpCo Inc.; Coeptis subsequently rebranded to Z Squared Inc. on April 27, 2026, and stockholders received approximately 43.9 million shares of Coeptis Common Stock as merger consideration.